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Purpose: To examine the psychometric properties of a Turkish version of the Diabetes Fear of Injecting
and Self-testing Questionnaire (D-FISQ).
Methods: Forward-backward translation of the D-FISQ from English into Turkish was conducted. Original
English and translated forms were examined by a panel group. Validity was investigated using content,
conﬁrmatory factor analysis, and divergent validity. Reliability was assessed using Cronbach a values,
item-total correlations, and intraclass correlations. The sample comprised 350 patients with diabetes.
Data were analyzed using SPSS 15.0 for Windows and LISREL 8.
Results: The content validity index for the panel members was .90, which indicated perfect content
validity; items in D-FISQ were clear, concise, readable, and distinct. Conﬁrmatory factor analysis
conﬁrmed the original construct of the D-FISQ. All items had factor loadings higher than the recom-
mended level of .40. The D-FISQ scores were discriminated by the level of anxiety. Reliability results were
also satisfactory. Cronbach a values were within ideal limits. Item-total correlation coefﬁcient ranged
from .72 to .86. In terms of test-retest reliability, intraclass correlation coefﬁcient was found to be over .90.
Conclusions: D-FISQ is a valid and reliable questionnaire in assessing needle-prick fear among Turkish
patients with diabetes. We recommend performing the Turkish D-FISQ in determining and screening
patients with diabetes who have fear related to self-insulin injection and ﬁnger-prick test. Thus, health
care professionals should be aware of the potential consequences of injection fear such as insulin misuse
and poor self-monitoring of blood glucose, which may have unfavorable effects on optimal diabetes
management.
Copyright © 2016, Korean Society of Nursing Science. Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Patients with type 1 diabetes require lifelong insulin therapy,
starting from the time of diagnosis. A partial insulin reservoir is
maintained in patients with type 2 diabetes, which enables these
patients to be well controlled only with oral antidiabetic drugs
without requiring insulin for a while. However, studies indicate
that patients with type 2 diabetes often become insulin-dependent
within 10 years of diagnosis [1]. For that reason, early and appro-
priate initiation of insulin therapy for patients with type 2 diabetes
is now clearly supported by American and European guidelines [2].
It is known that insulin is the most effective agent for
lowering glucose and achieving metabolic control. Studies haveattin Zaim University, Faculty
ciety of Nursing Science. Publishedshown the efﬁcacy of insulin therapy in preventing complications
of chronic diabetes including retinopathy, nephropathy, neurop-
athy, and macrovascular diseases, as well as in decelerating these
health problems in patients with both type 1 [3] and type 2
diabetes [4].
It is very important for patients who require insulin therapy to
understand the balance between medical nutrition therapy, exer-
cise, and insulin therapy, and to take appropriate measures to
maintain this balance. In this context, patients are expected to self-
monitor blood glucose and make appropriate adjustments to diet,
exercise program, and insulin doses, according to their blood
glucose results. Unfortunately, many patients do not achieve
satisfactory adherence to recommendations regarding their insulin
treatment. One reason for this is injection phobia [5].
However, relatively few studies have examined the prevalence
and effects of injection and self-testing phobia. The estimated
prevalence of injection phobia in pregnant women with diabetesby Elsevier. This is an open access article under the CC BY-NC-ND license (http://
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to be common. One study [7] found that 27.0% of children with
diabetes aged between 2 years and 21 years were affected by
needle phobia. Similarly, the prevalence of fear of self-testing and
fear of self-injection in adolescents with diabetes was 12.0% and
22.0%, respectively [8]. In the adult population [9], the prevalence
was reported at 0.2%e1.3% for injection fear and 0.6%e0.8% for fear
of self-testing, which were considerably lower than data from pa-
tients with gestational diabetes and childhood diabetes. As far as
we know, no studies have been performed on Turkish patients with
diabetes on this subject.
The fear of self insulin injection and ﬁnger-prick testing plays an
important negative role in patient adherence. A systematic review
that included 17 studies [5] conﬁrmed fear of these procedures as
reasons for nonadherence. Evidence also suggests that fear of self
insulin injection and ﬁnger-prick testing can lead to inaccuracy of
insulin doses, failure in self-monitoring blood glucose, and even
recording false blood glucose values without actually testing. As a
result, lack of adherence to diabetes management can cause de-
teriorations in metabolic control [8,10,11]. Furthermore, women
with injection phobia presented increased risk for adverse obstetric
outcomes, premature delivery, and higher neonatal morbidity [12].
Diabetes is a major public health issue in Turkey. Two cross-
sectional surveys that comprised nationally representative sam-
ples of more than 20,000 individuals showed that the prevalence of
diabetes was 7.2% and 16.5%, respectively [13,14]. There is no doubt
that the prevalence of diabetes has now reached epidemic pro-
portions, rising by 90.0% between 1998 and 2010. This means that
increasingly more patients need insulin and probably experience
fear of injection and ﬁnger prick.
For all the above reasons, it is essential that steps are taken to
decrease and manage patients' insulin injection fear and ﬁnger-
prick fear. Nurses are key professionals in determining patients'
insulin injection fear and ﬁnger-prick fear, and exploring the un-
derlying reasons. Then, they can employ appropriate interventions
including education and support to overcome these problems
because adherence to insulin treatment is the most effective tool in
achieving satisfactory metabolic control [15].
As far as we know, there are no studies in Turkish patients with
diabetes on injection and self-testing fear. Fear of self-injecting and
self-testing can be measured using the Diabetes Fear of Injecting
and Self-testing Questionnaire (D-FISQ), which is a reliable and
validated tool among patients with diabetes who need insulin
[7,10,16]. The advantage of using a standardized instrument such as
D-FISQ, is the ability to obtain comparative data of different pop-
ulations from international trials even though cultural adaptation is
needed. Therefore, we aimed to adapt the D-FISQ for the Turkish
population and investigate its psychometric properties.Methods
Setting and samples
This survey study was conducted at the diabetes outpatient
clinic of a university hospital between July 2008 and January 2009.
The proposed study sample consisted of all patients with diabetes
who met the eligibility criteria. Patients were eligible to participate
if they (a) were aged 18 years or more and literate, (b) had been
diagnosed as having diabetes for at least 1 year, (c) had been
receiving insulin therapy for at least 6 months, and (d) had intact
functions of hearing, speaking, and cognition. In total, 357 patients
met the eligibility criteria. However, seven patients refused to
participate in the study. Thus, 350 patients completed the study,
yielding a response rate of 98.0%.Although there is no concensus on absolute sample size for
validity studies, the number of subjects ranges from at least 5 in-
dividuals [17] to 20 individuals [18] for each item in the instrument
being used to perform the factor analysis. In this study, the in-
strument tested for psychometric properties contained two factors
with 15 items and the minimum number of participants required
was estimated to be 60. Accordingly, we included 350 patients in
the study, which was roughly equal to 23 subjects per item.
Instruments
Three intruments including the Basic Information Form, D-FISQ,
and the State Anxiety Inventory were used.
Basic Information Form
The Basic Information Form, which was developed by the au-
thors, consisted of two sections. The ﬁrst section contained ques-
tions on sociodemographic data including sex, age, and educational
status. In the second part, there were ﬁve questions on type of
diabetes, duration of diabetes, mean duration of insulin therapy,
daily number of insulin injections, and level of HbA1C.
D-FISQ
The D-FISQ was developed to determine fear regarding self-
injecting and self-testing among patients with diabetes who
required insulin therapy. The D-FISQ consists of a total of 15 items
in two dimensions on fear of self-injecting (FSI, 6 items), and fear of
self-testing (FST, 9 items). Each item is scored on a 4-point Likert
scale ranging from 0 to 3 (0¼ almost never, 1¼ sometimes, 2¼ often,
3 ¼ almost always). Assessment of the questionnaire can be per-
formed by calculating the mean raw score for each subdimension
and the overall questionnaire. It is recommended to calculate the
mean value when there are several replies of zero in the ques-
tionnaire. When raw scores are assessed, the FSI score ranges from
0 to 18, the FST score from 0 to 27, and the D-FISQ total score ranges
from 0 to 45with higher scores indicating increased fear [16]. In the
present study, calculations for subdimensions and the overall
questionnaire were initially performed with mean values because
there was a high number of zero replies. However, because stan-
dard deviations were too high in this calculation, the mean values
of the replies were reassessed after recoding as “1 ¼ almost never,
2 ¼ sometimes, 3 ¼ often, 4 ¼ almost always” upon consulting a
statistician. Thus, the FSI score ranged from 6 to 24, the FST score
from 9 to 36, and the D-FISQ-total score ranged from 15 to 60.
State Anxiety Inventory
The Turkish version of the State Anxiety Inventory was used to
evaluate state anxiety level. The lowest score that can be obtained
with this inventory is 20, and the highest score is 80. A total score of
20e39 indicates mild anxiety, 40e59 indicates moderate anxiety,
60e79 indicates severe anxiety, and 80 and over indicates panic or
crisis [19].
Procedures and data collection
The study consisted of three stages including translation, vali-
dation, and reliability testing of the D-FISQ.
Translation included a four stage process: (a) forward trans-
lation from English into Turkish; (b) backward translation from
Turkish into English; (c) examination of the original English,
Turkish, and backward translated English forms for discrepancies,
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(d) producing the ﬁnal D-FISQ Turkish version.
Validity of D-FISQ was assessed for content, construct, and
divergent validity. An expert panel including 12 diabetes nurses,
family physicians, diabetes specialists, dieticians, and a psycholo-
gist who was experienced in working with patients with diabetes
examined the content validity. All panel members scored items for
relevancy, simplicity, and clarity on a 4-ordinal-point scoring sys-
tem where 1 indicated not acceptable, 2 indicated somewhat
acceptable, 3 indicated acceptable, and 4 indicated highly acceptable.
The content validity index (CVI) for each item (I-CVI) and for the
total D-FISQ was then calculated. The I-CVI was evaluated with an
agreement degree among the panel experts on each item that
achieved a rating of 3 or 4. For example, if item 1 achieved a rating
of 3 or 4 by 10 of the 12 panel experts, I-CVI would be 83.3.
Following computing I-CVI for each item on the scale, we then
calculated the average I-CVI across items to get the CVI value for the
total D-FISQ. A value equal to or greater than .80 for both I-CVI and
CVI for the total D-FISQ was considered acceptable, and a value
equal to or greater than .90 for both dimensions was considered
perfect [20]. In our study, the CVI value of each item and for the
total D-FISQ exceed .90, which indicated perfect content validity by
means of items in D-FISQ, which are clear, concise, readable and
distinct.
Construct validity was evaluated to prove two-factor structure
of the D-FISQ. Divergent validity was tested to evaluate discrimi-
native power of D-FISQ. Reliability was assessed to test internal
consistency and test-retest stability of the D-FISQ. Construct and
divergent validity and internal consistency was tested in the total
sample.
Instruments were administered in the hospital education room
located in the diabetes outpatient clinic, a quiet, well-lit room
providing an atmosphere in which patients could concentrate on
completing the questionnaires without being disturbed. The Basic
Information Form was used to collect information on sociodemo-
graphic and diabetes- related variables. Afterwards, patients were
asked to self-administer the D-FISQ and State Anxiety Inventory.
For test-retest stability, we invited subjects who were able to
visit the clinic within 2 weeks of the ﬁrst evaluation. In total, 63
patients agreed tomake a second visit to clinic. Two days before the
scheduled date, a researcher phoned the patients to remind them of
their appointment. Of the 63 patients who agreed, 52 patients
made the second visit to the clinic and completed the D-FISQ.
The patients completed the D-FISQ in 4e12 minutes, with 95.0%
completing the questionaire in 6 minutes or less. The average time
required to complete the questionnaire was 5.5 minutes.
Data analysis
Descriptive statistics including means, ranges, standard de-
viations for continuous variables, and percentages for categorical
variables were used to summarize the participants' demographics
and disease-related characteristics.
Construct validity was evaluated by conﬁrmatory factor analysis
(CFA). In the CFA, Chi-square test (c2), goodness of ﬁt index (GFI),
adjusted goodness of ﬁt index (AGFI), comparative ﬁt index (CFI),
and root mean square error of approximation (RMSEA) were
examined as goodness of ﬁt indices. We assumed that c2 < 2.0 [21],
GFI > .95, AGFI > .90, CFI > .97, and RMSEA < .05 indicated perfect
ﬁt, whereas c2 < 3.0, GFI > .90, AGFI > .85, CFI > .95, and
RMSEA < .08 indicated acceptable ﬁt [22]. We expected that the FSI
and FST subscales would emerge from CFA as deﬁned in the original
study [16] and items related with FSI and FST would be grouped
together within a single factor. Factor loading for each item was
predicted to be > .40 [23].To examine divergent validity, we investigated whether mean
scores for the subdomains in D-FISQ andmean scores for the overall
questionnaire varied by anxiety level. One-way analysis of variance
(ANOVA) test was used to test divergent validity. A Bonferroni test
was applied after the ANOVA test to determine the meaningful
distinction.We hypothesized that individuals who hadmoderate or
severe anxiety would have higher fear scores as indicated in the
literature [10].
By means of reliability, internal consistency was assessed using
Cronbach a and item-total correlation. We accepted that a mini-
mum Cronbach a of .90 was ideal, Cronbach a > .80 was very
acceptable, and > .70 was acceptable as recommended in the
literature [23]. The correlation between each item and total was
analyzed with Pearson's correlation coefﬁcients. The threshold was
speciﬁed as > .40 for the item-total correlation coefﬁcient [23].
In terms of stability, test-retest correlation was assessed by
intraclass correlation coefﬁcient (ICC) in a sample of 52 patients.
The retest procedure was conducted 2 weeks after the ﬁrst evalu-
ation of the D-FISQ. Two weeks was judged to be the optimum
retest interval: this would be sufﬁciently long for patients to forget
their initial responses to the 15 items in D-FISQ, but not so long that
most fear factors of self-injecting and self-testing would change
substantially. Acceptable ICC was determined as .75 [24].
SPSS 15.0 for Windows [25] was used for all analyses including
descriptive statistics, CVI, Cronbach a coefﬁcient and Pearson's
correlation coefﬁcient analysis, One-way ANOVA, and Bonferroni
test. LISREL 8.0 [26] was used for CFA. Statistical signiﬁcance for all
analysis was taken at the 5% level.
Ethical considerations
We conducted the study in accordance with the Helsinki
Declaration and obtained approval from the local ethics committee
(20071473). All participants were informed about the purpose of
the study and were assured of conﬁdentiality. Informed written
consent was obtained from each patient before participation in the
study. We also obtained permission from Frank Snoek to adapt the
D-FISQ into Turkish and to study its psychometric properties.
Results
General characteristics of participants
The general characteristics of the participants are shown in
Table 1. The mean age of the participants was 47.3 years, the ma-
jority of themwere women, married, and had education at primary
school level. More than half of the participants (61.4%) had type 2
diabetes with a mean diabetes duration of 13 years. In all, 36.3% of
the participants had been under insulin treatment since diagnosis,
and 64.6% were injecting insulin three times or more a day. The
mean duration of insulin therapy was 8 years and the mean HbA1c
value was 8.1%.
Construct and divergent validity of D-FISQ
The CFA showed that the two-dimension model demonstrated a
better ﬁt-index compared with the single-dimension model
(Table 2). Factor loadings of each item, error ratios, and correlation
coefﬁcient between FSI and FST are presented in Table 3. Factor
loading for items in FSI ranged from .78 to .86, and factor loading for
items in FST ranged from .72 to .90. All items in FSI grouped under
the ﬁrst factor and all items in FST grouped under the second factor.
All observed variables were signiﬁcantly related to the latent var-
iables, and the correlation coefﬁcient between the two sub-
dimensions was .76.
Table 2 Model Tests and Comparisons (N ¼ 350).
Tested models c2/df GFI AGFI CFI RMSEA Dc2
Independent model 13.66 e e e e
Model 1 (Hypothesized
model with two factors)
1.00 .70 .59 .93 .018
Model 2 (Alternative model
with one factor)
1.90 .57 .43 .89 .240 96,925
Note. AGFI ¼ adjusted goodness of ﬁt index; CFI ¼ comparative ﬁt index;
GFI ¼ goodness of ﬁt index; RMSEA ¼ root mean square error of approximation.
Table 1 General Characteristics of Sample (N ¼ 350).
Variables n %
Gender
Women 190 54.3
Men 160 45.7
Marital status
Married 246 70.3
Unmarried 104 29.7
Educational status
Primary school graduates (5 yr education) 156 44.6
Secondary high school graduates (8e12 yr
education)
90 25.7
University graduated ( 14 yr education) 104 29.7
Type of diabetes
Type 1 135 38.6
Type 2 215 61.4
Diabetes regimen modality
Insulin since baseline 127 36.3
Oral hypoglycemic agents plus insulin 119 34.0
Initially oral hypoglycemic agents, currently
insulin
104 29.7
Frequency of insulin injections
Once a day 25 7.1
Twice a day 99 28.3
Three times or more a day 226 64.6
Age (Mean ± SD, yr) 47.31 ± 15.06
Duration of diabetes (Mean ± SD, yr) 12.94 ± 7.14
Duration of insulin therapy (Mean ± SD, yr) 8.30 ± 6.75
HbA1c value (Mean ± SD, %) 8.10 ± 1.48
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and FST scores and the total score of the D-FISQ were signiﬁcantly
higher among patients with moderate or severe levels of anxiety
than patients with mild anxiety.Table 3 Results of Conﬁrmatory Factor Analysis of Two-factor Model of D-FISQ
(N ¼ 350).
Variables Items Factor loading Error ratio
FSI When I have to inject myself
FSI1. I become restless .82 .33
FSI2. I feel tense .86 .25
FSI3. I feel afraid .78 .38
FSI4. I worry about it .85 .27
FSI5. I feel nervous .84 .29
FSI6. I brood about it .84 .30
FST When I have to prick my ﬁnger
FST7. I become restless .78 .40
FST8. I try to avoid it .72 .48
FST9. I feel tense .86 .25
FST10. I feel afraid .79 .38
FST11. I worry about it .83 .31
FST12. I feel nervous .90 .19
FST13. I brood about it .85 .27
FST14. I try to postpone it .78 .38
FST15. I get angry .89 .21
Correlation coefﬁcients between FSI and FST ¼ .76.
Note. D-FISQ ¼ Diabetes Fear of Injecting and Self-testing Questionnaire; FSI ¼ fear
of self-injecting; FST ¼ fear of self-testing.Reliability of the D-FISQ
Reliability results are presented in Table 5. Cronbach a was .96
for D-FISQ total, .93 and .95 for the subdimensions of FSI and FST,
respectively. The item-total correlation coefﬁcient ranged from .75
to .85 for FSI and from .72 to .86 for FST. In terms of the test-retest
stability, ICC was found to be .93, .95, and .96 for FSI, FST, and D-
FISQ, respectively.Discussion
The results of this study conﬁrmed that the Turkish D-FISQ has
satisfactory psychometric properties including validity and
reliability.Construct and divergent validity of D-FISQ
This study conﬁrmed the construct and divergent validity of the
D-FISQ. To our knowledge, this is the ﬁrst CFA examination of D-
FISQ. Based on the satisfactory factor loadings for each item
exceeding .40, as recommended in the literature [23], two factors
emerged in CFA, which was similar to the original factor structure
of D-FISQ; a high correlation coefﬁcient between the two factors
conﬁrmed construct validity for the questionnaire, although GFI
and AGFI did not meet the expected criteria.
There are varying suggestions in the literature about the num-
ber, type, and cut-off values for GFI. However, the RMSEA is one of
the most sensitive and reliable indices among them [27], and
regardless of other ﬁt indices, structural equation modeling is
acceptable if RMSEA is not larger than .10 [28]. CFI is also one of the
most popularly reported ﬁt indices because it is one of the mea-
sures least affected by sample size [29].
In CFA, we found that a hypothesis model with two factors
provided a better explanation of changes (variance-covariance)
observed in the data set. An RMSEA of about .018 was considered
evidence of perfect ﬁt [22,28]. In addition, a value of c2 less than 1.0
indicated perfect ﬁt [21], CFI of about .93 indicated acceptable ﬁt
[22] of the two-factor model. GFI and AGFI did not meet the ex-
pected criteria. This result might be related to our large sample size.
It is recommended not to use these measures as standard ﬁt indices
because they tend to be lower when the sample size is over 200
[29].
In our study, the adequacy of the two-factor model must also be
considered in terms of the parameter estimates: ﬁrst, all factor
loadings were high and positive, which indicated that all items
were strongly related with their factors; second, correlation be-
tween FSI and FST was very strong, thereby suggesting that the
nucleus of both scales was similar, although particular discrep-
ancies did exist. Third, three of the GFIs, especially RMSEA of the
two-factor model, were more superior than the acceptable limit.
Thus, we can say that results of the construct validity of D-FISQ
were satisfactory.
Similar to our results, a previous study demonstrated two fac-
tors, all items contributed to only one factor with factor loading
exceeding .40 [10]. In another study, two factors were also obtained
[30]. These results suggest that the underlying components of the
Turkish D-FISQ were similar to the original D-FISQ.
The present study also showed that D-FISQ and two of its sub-
dimensions could discriminate patients with mild, moderate, and
severe anxiety level, as we expected. Our results correlatewell with
the a previous study [10]. We can conclude that D-FISQ can
discriminate patients with different levels of anxiety.
Table 4 Findings on Discriminative Validity of D-FISQ (N ¼ 350).
Variables Mild anxiety
(n ¼ 256)
Moderate anxiety
(n ¼ 89)
Severe anxiety
(n ¼ 5)
F p pa
Mild anxiety vs. moderate
anxiety
Moderate anxiety vs. severe
anxiety
Mild anxiety vs. severe
anxiety
FSI 7.06 ± 2.72 8.88 ± 3.53 12.20 ± 6.72 17.88 < .001 < .001 .003 < .001
FST 10.75 ± 4.03 12.40 ± 4.50 19.80 ± 4.83 14.77 < .001 < .001 .008 < .001
D-FSIQ
total
17.82 ± 6.08 21.29 ± 7.37 32.17 ± 17.13 18.72 < .001 < .001 .007 < .001
Note. D-FISQ ¼ Diabetes Fear of Self-injecting and Self-testing Questionnaire; FSI ¼ fear of self-injecting; FST ¼ fear of self-testing.
a Bonferroni test p value.
Table 5 Results of Internal Consistency and Test-retest Reliability.
Variables Items Item-total
correlation
Cronbach a if item is
deleted
FSI When I have to inject myself
FSI1. I become restless .79 .91
FSI2. I feel tense .85 .90
FSI3. I feel afraid .75 .92
FSI4. I worry about it .81 .92
FSI5. I feel nervous .80 .92
FSI6. I brood about it .80 .92
Cronbach a ¼ .93 (N ¼ 350) ICC ¼ .93 (n ¼ 52)
FST When I have to prick my ﬁnger
FST7. I become restless .78 .95
FST8. I try to avoid it .72 .95
FST9. I feel tense .86 .94
FST10. I feel afraid .78 .94
FST11. I worry about it .80 .94
FST12. I feel nervous .85 .94
FST13. I brood about it .81 .94
FST14. I try to postpone it .78 .94
FST15. I get angry .84 .94
Cronbach a ¼ .95 (N ¼ 350) ICC ¼ .95 (n ¼ 52)
D-FSIQ
total
Cronbach a ¼ .96 (N ¼ 350) ICC ¼ .96 (n ¼ 52)
Note. D-FISQ ¼ Diabetes Fear of Self-injecting and Self-testing Questionnaire;
FSI ¼ fear of self-injecting; FST ¼ fear of self-testing; ICC ¼ intraclass correlation
coefﬁcient.
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The reliability ﬁndings in our study indicated satisfactory re-
sults. First, Cronbach a values were ideal for two subdimensions
and the total questionnaire [23]. Second, the item-total correlations
for all items in the FSI and FST exceeded the accepted standard [23].
Finally, ICC results based on a 2-week interval supported evidence
for the overtime stability of the Turkish D-FISQ.
Our results of Cronbach a were compatible with ﬁndings from
previous studies in which Cronbach a values were between .87 to
.94 for FSI and .90 to .97 for FST [7,10,16].
In this study, item-total correlations, which were over the
accepted standard, suggested that the items measured phenomena
pertinent to the construct [23]. Our results were also compatible
with a study inwhich item-total correlations ranged from .55 to .72
in FSI and from .48 to .73 in FST, all of which were within accepted
standards [10].
To our knowledge, the test-retest stability of the D-FISQ was not
assessed in the original study. In the present research, the test-
retest approach was favored for the D-FISQ, as it has the advan-
tages of being easy to perform in the study program, being
appropriate for a self-report questionnaire. Also, it has recently
been presented as having strong internal consistency.
In our study, the 2-week test-retest stability results for FSI and
FST were perfect compared with ﬁndings reported in a previous
study [10] inwhich the test-retest reliability was reported as .58 for
FSI and .50 for FST after 3 months, and .68 for FSI and .50 for FST
after a 15-month interval. The authors concluded that a test-retestprocedure over a shorter period of time as 1e2 weeks may be
useful. In our study, 2 weeks was judged to be the optimum retest
interval. A study from Spain replicated our stability results (the
test-retest reliability of FSI and FST was .85 and .94, respectively) in
their sample after a 2-week interval [30].
Based on the reliability results mentioned above, we conclude
that the FSI and FST domain in the D-FISQ was consistent and
replicated.
Conclusion
Based on the validity and reliability analyses, it can be concluded
that the D-FISQ with two factors is a reliable and valid question-
naire for assessing fear of needle-prick among Turkish patients
with diabetes.
Clinical use of the Turkish D-FISQ helps determine and screen
patients with diabetes who have fear regarding self-injection of
insulin and the ﬁnger-prick test. In addition, the ﬁndings suggest a
need for further research to explore why some patients with dia-
betes fear self-injection of insulin and ﬁnger-prick testing more
than other patients do. These evaluations would also facilitate
supporting patients in this context. Finally, healthcare professionals
should be aware of the potential effects of fear, including de-
linquencies in insulin injections and poor self-monitoring of blood
glucose during diabetes management in people with diabetes who
have adjustment problems and poor metabolic control. Patients
with diabetes who have fear of self-injection and ﬁnger-prick
testing should be followed up closely to prevent metabolic deteri-
oration and should also be educated on how they can manage their
fear.
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